Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Replicative Cell Senescence

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Ectodermal origins of the skin-brain axis: a novel model for the developing brain, inflammation, and neurodevelopmental conditions.

Molecular psychiatry·2022

Same author

Eczema and related atopic diseases are associated with increased symptom severity in children with autism spectrum disorder.

Translational psychiatry·2022

Same author

Radiographer-led online image guided adaptive radiotherapy: A qualitative investigation of the therapeutic radiographer role.

Radiography (London, England : 1995)·2021

Same author

International survey; current practice in On-line adaptive radiotherapy (ART) delivered using Magnetic Resonance Image (MRI) guidance.

Technical innovations & patient support in radiation oncology·2020

Same author

The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature.

The Journal of dermatological treatment·2020

Search research articles

Related Experiment Video

Updated: May 29, 2026

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Germ cell tumour: late recurrence after 43 years.

S Mukhtar¹, J Beatty, S Agrawal

¹Kent and Canterbury Hospital, UK. sohayl_m@hotmail.co.uk

Annals of the Royal College of Surgeons of England

|September 28, 2011

Summary

Late relapse of testicular germ cell tumors is possible, even after 43 years. This case highlights the need for extended surveillance beyond current guidelines for these rare occurrences.

Related Experiment Videos

Last Updated: May 29, 2026

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Area of Science:

Oncology
Urology
Pathology

Background:

Testicular germ cell tumors (GCTs) are the most common solid malignancy in young men.
Current European Association of Urology guidelines recommend at least five years of surveillance for GCTs due to high relapse rates.
The optimal duration for long-term follow-up remains unclear.

Observation:

A patient with a suspected pure seminoma, which showed yolk sac differentiation, experienced a relapse 43 years after initial diagnosis and treatment.
This represents the longest documented time to relapse for a GCT, significantly exceeding the previously recorded 32 years for malignant teratoma with de-differentiation.

Findings:

This case report confirms that late relapse of testicular germ cell tumors can occur, irrespective of the initial stage or type.
The observed 43-year surveillance period underscores the potential for GCTs to remain dormant for decades before relapsing.

Implications:

Extended surveillance protocols for testicular germ cell tumors may be warranted, potentially beyond the standard five-year recommendation.
Further research is needed to establish definitive long-term follow-up guidelines for GCT survivors to account for exceptionally late relapses.
This case emphasizes the importance of lifelong vigilance in managing patients treated for GCTs.